Simotinib

CAS No. 944258-89-3

Simotinib( SIM6802 | SIM-6802 )

Catalog No. M16764 CAS No. 944258-89-3

Simotinib (SIM-6802) is a novel potent EGFR inhibitor for treatment of NSCLC.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 258 In Stock
50MG 1269 In Stock
100MG 1791 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Simotinib
  • Note
    Research use only, not for human use.
  • Brief Description
    Simotinib (SIM-6802) is a novel potent EGFR inhibitor for treatment of NSCLC.
  • Description
    Simotinib (SIM-6802) is a novel potent EGFR inhibitor for treatment of NSCLC.Lung Cancer Phase 1 Clinical.
  • In Vitro
    Simotinib inhibits in a dose-dependent manner EGFR and the growth of human A431 tumor cells with high expression of EGFR, with no significant activity on other investigated kinases.
  • In Vivo
    Simotinib has been shown to exert its antitumor activity by inhibiting EGFR phosphorylation in nude xenograft model.
  • Synonyms
    SIM6802 | SIM-6802
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR
  • Research Area
    Cancer
  • Indication
    Lung Cancer

Chemical Information

  • CAS Number
    944258-89-3
  • Formula Weight
    500.95
  • Molecular Formula
    C25H26ClFN4O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (249.53 mM)
  • SMILES
    COC1=C(OCCN2CC3(C4(OCCO4)C2)CC3)C=C(C(NC5=CC=C(F)C(Cl)=C5)=NC=N6)C6=C1
  • Chemical Name
    N-(3-chloro-4-fluorophenyl)-6-(2-(5,8-dioxa-11-azadispiro(2.0.4.3)undec-11-yl)ethoxy)-7-methoxy-4-quinazolinamine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Huang L, et al. Anticancer Drugs. 2016 Apr;27(4):300-11.
molnova catalog
related products
  • Befotertinib

    Befotertinib is an inhibitor of EGFR tyrosine kinase and can be used for studies about EGFR T790M-positive non-small cell lung cancer.

  • HS-10296

    Hs-10296 is an inhibitor of EGFR activation mutation and tolerant mutation of EGFR T790M which has only limited activity against wild-type EGFR.

  • Pyrotinib

    Pyrotinib (SHR-1258)?is a potent and selective EGFR/HER2 dual inhibitor with IC50 of 13/38 nM, respectively.